Provided herein are methods compositions and kits for the treatment of an enteric nervous system disorder. Such methods may comprise administering to a subject an effective amount of a phenothiazine compound a peripherally restricted dopamine decarboxylase inhibitor and/or a peripherally restricted dopamine D2 receptor antagonist that does not substantially inhibit hERG channels